
WASHINGTON, Oct. 8 (UPI) -- A U.S. Food and Drug Administration spokeswoman said the agency is preparing a warning about the dangers of drugs used to enhance heart-related diagnoses.
The FDA has been investigating reports of deaths and serious cardiopulmonary reactions in patients who took drugs designed to assist in diagnosing heart problems with ultrasound imaging machines, the Wall Street Journal reported Monday.
The injected drugs, which include Definity, manufactured by Bristol-Myers Squibb Co. of New York, and Optison, from General Electric Co., Fairfield, Conn., contain microscopic gas-filled spheres that allow for sharper pictures to be taken of a patient's heart during an echocardiography procedure.
The FDA spokeswoman said the agency will alert the healthcare industry about "these serious risks and... provide guidance regarding the safe use" of the drugs. She said the drug makers have also agreed to update their labels to reflect the risks.
|
|
|
| Additional Science News Stories | |
CAMBRIDGE, Ohio, Feb. 9 (UPI) --
An Ohio father was charged Thursday with felony domestic violence for allegedly putting his 3-year-old son in a clothes dryer and turning it on.
|
NEW YORK, Feb. 9 (UPI) --
Macaulay Culkin is in "perfectly good health," his publicist said after the former child star was photographed looking gaunt and disheveled in New York.
|
GREENBELT, Md., Feb. 9 (UPI) --
U.S. astronomers say a distant galaxy puzzles them because it contains a high number of stars younger than their neighbors, which goes against current theory.
|
UPI horoscopes for Friday, Feb. 10, 2012.
|
| Stories | Photos | People | Comments |
View Caption